3 FDA topics to watch in 2018
Many of the proclamations the FDA has made under Scott Gottlieb will come to fruition, or at least to bud, in 2018.
As the year winds down, STAT reporters are taking a look at the stories they’re most eager to track in 2018. Find all our “three to watch” series here.
It’s been a busy year for the Food and Drug Administration — since Commissioner Scott Gottlieb was in May, he has led the agency with an ambitious agenda, tackling everything from prescription opioid addiction to tobacco use to.
